EP2522318A1 — Guide device for intraocular injection
Assigned to Sanofi Aventis Deutschland GmbH · Expires 2012-11-14 · 14y expired
What this patent protects
Described is a guide device (10) for intraocular injection comprising a base plate (11) having an inner surface (13) and an outer surface (19), a handle (17) formed on the outer surface (19), and a hole (15) formed in the base plate (11) and extending through the inner and outer …
USPTO Abstract
Described is a guide device (10) for intraocular injection comprising a base plate (11) having an inner surface (13) and an outer surface (19), a handle (17) formed on the outer surface (19), and a hole (15) formed in the base plate (11) and extending through the inner and outer surfaces. The inner surface (13) is adapted to contact an eye ball.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.